GlaxoSmithKline CEO Emma Walmsley has reportedly received a pay cut of 14 per cent after the company missed an internal profit target for sales of routine vaccinations against other diseases.
According the pharmaceutical giant’s annual report, Ms Walmsley’s total remuneration for 2020 came in at seven million pounds (€8.2 million).
The cut, according to comments by Non-Executive Director Urs Rohner in the report, partly reflected a missed internal profit target for biopharmaceuticals, mainly due to lockdowns stopping people from receiving routine vaccinations which cut into the CEO’s bonus.
Ms Walmsley was appointed CEO in 2017, and has made great strides in the company’s restructuring efforts, as it works to split its consumer and pharmaceutical businesses.
GlaxoSmithKline has been among the frontrunners in the effort to develop COVID-19 vaccines and treatments, with the company’s offering, which was developed in conjunction with the University of Oxford, having been approved for use in over 50 countries.
Last month, pharmaceutical chiefs came under fire as EU leaders prioritised the acceleration of COVID-19 vaccination rollouts, with pharmaceutical companies being pressed to abide by delivery commitments.
Tanya Chetcuti appointed Director for Digital Workplace and Infrastructure at the EC
This major appointment for Tanya Chetcuti comes after more than 16 years at Digit European Commission.
‘It’s a privilege’: Rosanne Bonnici becomes only Maltese member of International Trust Law Academy
“It is a privilege to be recognised alongside such a distinguished group of practitioners from around the world,” she said.
EBO CEO: New investment will support healthcare AI company’s international expansion
The Malta-founded company plans to deepen its presence in the UK and Southeast Europe while expanding into the US.
AeroItalia VP: How €5 million helped airline to seize opportunity from market disruption
Marco Carcioffo says AeroItalia's relatively simple consolidation strategy allowed it to capitalise on an unusual opening in Italy's aviation market.
